Open Access Open Access  Restricted Access Subscription Access
Open Access Open Access Open Access  Restricted Access Restricted Access Subscription Access

Formulation and Evaluation of Mucoadhesive Buccal Patches of Terbutaline Sulphate


Affiliations
1 Department of Pharmaceutics, Shree Ambabai Talim Sanstha’s Diploma in Pharmacy College, Miraj-416 414, District-Sangli, Maharashtra, India
     

   Subscribe/Renew Journal


The aim of the study was to develop and optimize formulations of mucoadhesive patches of Terbutaline sulphate. The patches were prepared by the solvent casting method using Hydroxyl propyl methyl cellulose (HPMC E-15) as basic polymer along with Carbopol 934, Eudragit RL 100, and Chitosan were taken in different concentration. The patches were found to be smooth in appearance, uniform in thickness, weight uniformity, drug content, swelling behavior, and surface pH. Terbutaline Sulphate Buccal patch of Formulation 5 (TBP5) containing 400 mg of HPMC, 200 mg of Eudragit RL 100 have optimum bioadhesive strength, in-vitro residence time showed a release of 83.40 % after 15 hours and can meet the ideal requirement for sustained release buccal devices, which can be good way to bypass the extensive hepatic first pass metabolism and increase bioavailability.

Keywords

Mucoadhesive, Buccal Patches, Terbutaline Sulphate, HPMC, Eudragit.
Subscription Login to verify subscription
User
Notifications
Font Size


Abstract Views: 314

PDF Views: 2




  • Formulation and Evaluation of Mucoadhesive Buccal Patches of Terbutaline Sulphate

Abstract Views: 314  |  PDF Views: 2

Authors

Suresh A. Marnoor
Department of Pharmaceutics, Shree Ambabai Talim Sanstha’s Diploma in Pharmacy College, Miraj-416 414, District-Sangli, Maharashtra, India

Abstract


The aim of the study was to develop and optimize formulations of mucoadhesive patches of Terbutaline sulphate. The patches were prepared by the solvent casting method using Hydroxyl propyl methyl cellulose (HPMC E-15) as basic polymer along with Carbopol 934, Eudragit RL 100, and Chitosan were taken in different concentration. The patches were found to be smooth in appearance, uniform in thickness, weight uniformity, drug content, swelling behavior, and surface pH. Terbutaline Sulphate Buccal patch of Formulation 5 (TBP5) containing 400 mg of HPMC, 200 mg of Eudragit RL 100 have optimum bioadhesive strength, in-vitro residence time showed a release of 83.40 % after 15 hours and can meet the ideal requirement for sustained release buccal devices, which can be good way to bypass the extensive hepatic first pass metabolism and increase bioavailability.

Keywords


Mucoadhesive, Buccal Patches, Terbutaline Sulphate, HPMC, Eudragit.